Diels-Alder cycloaddition of 10 followed by Wittig homologation and intramolecular diene cyclozirconation of the resulting triene under equilibrating conditions led to the tricyclic 6-6-5 ketone 5 with high diastereocontrol. The derived R-azido ketone 16 cyclized efficiently to the heptacyclic pyrazine core of ritterazine N.
Introduction
The cephalostatins, represented by cephalostatin 1 (1), 1 and ritterazines, represented by ritterazine N (2), comprise a family of 45 structurally unprecedented marine products with selective cytotoxicity against human tumors. The cephalostatins, from the Indian Ocean hemichordate Cephalodiscus gilchristi, and the ritterazines, from the Japanese marine tunicate Ritterella tokioka, are clearly related (ritterazine K, for example, contains 2 the "left half" of cephalostatin 7), although identical alkaloids have not yet been found in both species. Isolated from C. gilchristi, cephalostatin 1 exhibits remarkable cytotoxic activity 3 against P388 murine leukemia cells with IC 50 values of 10 -4 -10 -6 ng/mL. Ritterazine B treated HL-60 cells become multinucleated, leading at 20 nM to apoptosis by a novel mechanism. Ritterazine N shows the same profile, but at nearmicromolar concentrations. It is particularly exciting that this family of alkaloids induces apoptosis in apoptosis-resistant malignant cell lines.
These compounds are isolated in only microgram quantities from natural sources. If their potent physiological activity is to be pursued, they must be prepared by synthesis. Fuchs and coworkers have completed much elegant work toward the synthesis of the cephalostatins and ritterazines from steroid precursors. 4 (1) For the isolation and activity of the ritterazines and cephalostatins, see: (a) Pettit, G. R.; Tan, R.; Xu, J.; Ichihara, Y.; Williams, M. D.; Boyd, M. R. J. Nat. Prod. 1998, 61, 955. (b) Fukuzawa, S.; Matsunaga, S.; Fusetani, N. J. Org. Chem. 1997, 62, 4484. (2) Ganesan, A. Angew. Chem., Int. Ed. Engl. 1996, 35, 611. (3) We report the preparation of the symmetrical heptacyclic core of the spiro 6-6-5-5 ritterazines.
Results and Discussion
Retrosynthetic Analysis. We envisioned (Scheme 1) that the symmetrical pyrazine 2 might be prepared by reductive dimerization of the azido ketone 3. The ketone would be available by convergent coupling of the sulfonate 4 with the tricyclic ketone 5. It was particularly encouraging that computational studies on the four diastereomeric zirconacycles derived from 6 led to the prediction that the equilibrating cyclozirconation should proceed with substantial stereocontrol. We report the preparation of the ketone 5, by cyclozirconation 5,6 of the triene 6, and the dimerization of 5 to the heptacyclic pyrazine core of ritterazine N 2.
Preparation of Triene 6. Diels-Alder cycloaddition (Scheme 2) of the aldehyde derived from 8 7 to butadiene delivered the aldehyde 10. This set the relative configuration of the A-B ring system. Another advantage of this approach is that it installs the ∆-2 alkene (steroid numbering) needed for pyrazine construction. Wittig methylenation of 10 then provided the triene 6.
Computational Analysis. The four diastereomers of the zirconacycle (Scheme 3) will be equilibrating 5, 6 under the conditions of the reaction. The cyclization is readily reversible, even though the equilibrium lies toward the cyclized product. To predict diastereoselectivity, it was important to evaluate the relative thermodynamic stability of the diastereomeric zirconacycles. ZINDO calculations indicated that zirconacycle 11a (which would give tricyclic ketone 5, Scheme 2) was more stable than its nearest competitor by 2.24 kcal/mol.
Oxygenation of the Zirconacycle. We initially ran the cyclozirconation of 6 (Scheme 4) at room temperature. After 3 h, the intermediate zirconacycles were converted to the diols by exposure to molecular oxygen. We recovered a dominant kinetic product 12c from this reaction, corresponding to intermediate zirconacycle 11c (Scheme 3). The structure of diol 12c was confirmed by X-ray analysis. A minor diol 12b was also isolated. On reacting the triene 6 with zirconocene dichloride and 2 equiv of butyllithium, heating for 4 h at 70°C
, and then oxygenating, we recovered a new dominant diol, derived from the equilibrated zirconacycle 11a. This was assigned the structure 12a.
Time Course of the Cyclozirconation. An HPLC assay was developed for the benzoates of 11a-c. To determine the optimum time and temperature for equilibration of the zirconacycles, a time and temperature study was performed (Figure 1) . After 1 h at room temperature, the 13a/13b/13c ratio was 10:25:65. After an additional 1 h at 55°C, the ratio was SCHEME 1 SCHEME 2 SCHEME 3
Taber and Taluskie 45:10:45. After a third hour at 70°C, 13a was the single dominant product.
These results indicated that the reaction is complete after 3 h total and that there was no need to heat it past 2 h at 70°C in order for the zirconacycles to fully equilibrate. This helped to improve our yields, since significant degradation was observed on prolonged heating. Using the results from the time and temperature study, the cyclozirconation of 6 was maintained at 70°C for 1.5 h to equilibrate the zirconacycles. The resulting solution was exposed 6 to carbon monoxide, and a single dominant ketone 5 was formed.
Preparation of the Heptacyclic Pyrazine. Before proceeding with the preparation of 4 (Scheme 1), we thought it wise to explore the prospective azido ketone dimerization (Scheme 5). As expected from the steroid precedent, 8 epoxidation of 5 proceeded to give 14 as a single major diastereomer. Opening of the epoxide 9 with NaN 3 also proceeded to give a single product 14 from the preferred diaxial opening of the epoxide. Oxidation then gave ketone 15.
In the past, such azido ketones have been reduced to the dimeric pyrazines using phosphines. 10 These reactions did not work well with our substrate. We were pleased to observe, however, that reduced Te 11 efficiently dimerized 16 to give 17. This is the first preparation of the heptacyclic pyrazine core of the 6-6-5-5 ritterazines.
Conclusion
We expect that the key Diels-Alder/Wittig/diene cyclozirconation approach illustrated here, supported by ZINDO calculations, will be a general strategy for the stereocontrolled construction of polycarbacyclic target structures. The tricyclic ketone 5 may become a useful "truncated steroid" platform for drug discovery. 
SCHEME 4 SCHEME 5
Computationally Guided Organometallic Chemistry Experimental Section Cyclic Aldehyde 10. To a stirred suspension of activated manganese dioxide (123.0 g, 1.418 mol) and dry CH 2 Cl 2 (284 mL) was added allylic alcohol 8 neat (20.0 g, 142 mmol) dropwise over 30 min. The residual allylic alcohol was rinsed into the reaction mixture with 5 mL of CH 2 Cl 2 . After 48 h, the mixture was filtered through Celite using an additional 3 × 300 mL of CH 2 Cl 2 . The organic extract was concentrated, and the aldehyde was used crude in the next reaction: TLC R f (PE/MTBE ) 9/1) ) 0.47; 1 H NMR (400 MHz, CDCl 3 ) δ 9.40 (1H, s), 6.48-6.52 (1H, t, J ) 7.25), 5.77-5.87 (1H, m), 5.01-5.10 (2H, m), 2.44-2.49 (2H, m), 2.24-2.30 (2H, m), 1.75 (3H, s); 13 C NMR δ u 28. 3, 32.4, 115.9, 139.7; d 9.4, 137.1, 153.8, 195.3; IR (film) 3350, 3079, 2979 IR (film) 3350, 3079, , 2925 IR (film) 3350, 3079, , 2818 IR (film) 3350, 3079, , 2762 IR (film) 3350, 3079, , 2711 IR (film) 3350, 3079, , 1688 IR (film) 3350, 3079, , 1642 IR (film) 3350, 3079, , 1442 IR (film) 3350, 3079, , 1404 IR (film) 3350, 3079, , 1379 IR (film) 3350, 3079, , 1359 IR (film) 3350, 3079, , 1320 IR (film) 3350, 3079, , 1251 IR (film) 3350, 3079, , 1188 IR (film) 3350, 3079, , 1068 The aldehyde (7.16 g, 51.1 mmol) was dissolved in dry CH 2 Cl 2 , and methylene blue (10 mg) was added. The reaction flask was then cooled to -30°C. Butadiene (21.7 mL) was condensed using a coldfinger condensor, taken up in cold CH 2 Cl 2 (118 mL), and added to the reaction mixture. Triflic acid in CH 2 Cl 2 (12 mL, 6.0 mmol) was added dropwise at -10°C over 30 min. The reaction mixture was warmed to room temperature and stirred for an additional 5 h. The reaction mixture was partitioned between CH 2 Cl 2 and saturated aqueous NaHCO 3 . The combined organic extract was dried (Na 2 SO 4 ) and concentrated. The residue was chromatographed to afford the aldehyde 10 (6.18 g, 68% yield) as a colorless oil: TLC R f (PE/MTBE ) 9/1) ) 0. 2, 30.2, 31.8, 32.0, 48.4, 115.2; d 14.0, 35.4, 123.6, 126.0, 138.4, 206.4; IR (film) 3076, 3027, 2976 IR (film) 3076, 3027, , 2921 IR (film) 3076, 3027, , 2835 IR (film) 3076, 3027, , 2689 IR (film) 3076, 3027, , 1728 IR (film) 3076, 3027, , 1640 IR (film) 3076, 3027, , 1454 IR (film) 3076, 3027, , 1433 IR (film) 3076, 3027, , 1189 Triene 6. To methyltriphenylphosphonium bromide (17.98 g, 50.33 mmol) and potassium tert-butoxide (5.28 g, 47.19 mmol) was added THF (125 mL). The reaction mixture was stirred at room temperature for 30 min, and then aldehyde 10 (5.60 g, 31.46 mmol) in THF (10 mL) was added dropwise over 15 min. After an additional 30 min, the reaction mixture was partitioned between diethyl ether and, sequentially, saturated aqueous NH 4 Cl and brine. The combined organic extract was dried (Na 2 SO 4 ) and concentrated. The residue was chromatographed to afford the triene 6 (5.09 g, 92% yield) as a colorless oil: TLC R f (PE/ CH 2 Cl 2 ) 9.5/0. 4, 30.0, 32.2, 38.7, 39.1, 111.3, 114.5; d 16.6, 40.1, 125.4, 125.9, 139.3, 149.0; IR (film) 3079, 3023, 2974 IR (film) 3079, 3023, , 2918 IR (film) 3079, 3023, , 2880 IR (film) 3079, 3023, , 2833 IR (film) 3079, 3023, , 1823 IR (film) 3079, 3023, , 1639 IR (film) 3079, 3023, , 1432 IR (film) 3079, 3023, , 1413 IR (film) 3079, 3023, , 1373 IR (film) 3079, 3023, , 1350 IR (film) 3079, 3023, , 1327 IR (film) 3079, 3023, , 1225 IR (film) 3079, 3023, , 1188 IR (film) 3079, 3023, , 1001 ; LRMS m/z (rel intensity) 176 (<1), 161 (6), 147 (6), 134 (13), 122 (21), 107 (33), 93 (43), 81 (100), 77 (17), 67 (16), 55 (10), 41 (14); HRMS calcd for C 13 H 20 176.156501, obsd 176.155848.
Ketone 5. Zirconocene dichloride (992 mg, 3.4 mmol) was added to a 50 mL round-bottomed flask. Triene 6 (500 mg, 2.8 mmol) in toluene (8 mL) was added to the flask. The reaction mixture was cooled to -78°C, and n-BuLi was added (2.17 M in hexanes, 3.10 mL) via syringe. The reaction was warmed to room temperature over 15 min and then was heated to 70°C for 1.5 h. The reaction was cooled to room temperature, and then 8 mL of THF was added. CO was bubbled through the reaction mixture for 45 min. The reaction was stirred under a CO atmosphere for 24 h. Glacial acetic acid (1.18 mL) was added to the reaction mixture. The reaction mixture was partitioned between EtOAc and a 1:1 mixture of 5% aqueous H 2 SO 4 and saturated aqueous Na 2 SO 4 . The combined organic extract was dried (Na 2 SO 4 ) and concentrated. The residue was chromatographed to afford the ketone 5 (337 mg, 59% yield) as a colorless oil: TLC R f (PE/MTBE ) 8/2) ) 0.53; 1 H NMR (400 MHz, CDCl 3 ) δ 5.60-5.65 (2H, m), 2.36-2.42 (1H, dd, J ) 6 Hz, J ) 17 Hz), 2.17-2.23 (1H, dd, J ) 6 Hz, J ) 17 Hz), 1.93-2.03 (4H, m), 1.75-1.82 (4H, m), 1.47-1.59 (3H, m), 1.22-1.36 (2H, m), 0.81 (3H, s); 13 C NMR δ u 28. 9, 29.8, 32.1, 34.1, 39.4, 40.0, 46.3, 218.4; d 11.0, 37.5, 41.3, 54.6, 125.3, 126.3; IR (film) 3467, 3019, 2961 IR (film) 3467, 3019, , 2914 IR (film) 3467, 3019, , 2852 IR (film) 3467, 3019, , 1744 IR (film) 3467, 3019, , 1651 IR (film) 3467, 3019, , 1445 IR (film) 3467, 3019, , 1431 IR (film) 3467, 3019, , 1406 IR (film) 3467, 3019, , 1384 IR (film) 3467, 3019, , 1366 IR (film) 3467, 3019, , 1201 IR (film) 3467, 3019, , 1153 LRMS m/z (rel intensity) 204 (61) , 189 (7), 176 (6), 162 (13), 150 (41), 122 (100), 107 (27), 93 (41), 79 (30), 67 (10) , 53 (9), 41 (12); HRMS calcd for C 14 H 20 O 204.151415, obsd 204.151768 .
Epoxide 14. To a stirred solution of ketone 5 (37 mg, 0.18 mmol) and CH 2 Cl 2 (1.2 mL) was added m-CPBA (43 mg, 0.25 mmol). After 30 min, the reaction mixture was partitioned between CH 2 Cl 2 and saturated aqueous NaHCO 3 . The combined organic extract was dried (Na 2 SO 4 ) and concentrated. The residue was chromatographed to afford the epoxide 14 (34 mg, 87% yield) as a colorless oil: TLC R f (CH 2 Cl 2 /acetone ) 9.5/0.5) ) 0.43; 1 H NMR (400 MHz, CDCl 3 ) δ 3.23 (1H, s), 3.14-3.16 (1H, m), 2.36-2.39 (1H, m), 2.17-2.24 (1H, dd, J ) 7 Hz, J ) 17 Hz), 1.90-2.02 (3H, m), 1.77-1.83 (3H, m), 1.48-1.59 (5H, m), 1.18-1.31 (2H, m), 0.83 (3H, s); 13 C NMR δ u 28.6 (2), 31.9, 33.3, 38.8, 39.2, 46.1, 217.9; d 12.5, 36.2, 37.5, 50.6, 52.5, 54.2; IR (film) 3053, 2921 IR (film) 3053, , 2850 IR (film) 3053, , 1741 IR (film) 3053, , 1604 IR (film) 3053, , 1448 IR (film) 3053, , 1406 IR (film) 3053, , 1380 IR (film) 3053, , 1320 IR (film) 3053, , 1265 IR (film) 3053, , 1169 IR (film) 3053, , 1144 LRMS m/z (rel intensity) 220 (41), 205 (37), 192 (100), 187 (13), 174 (14), 162 (27) Azido Alcohol 15. To a stirred solution of epoxide 14 (146.4 mg, 0.67 mmol) in an 8:1 methanol/water solution (3.35 mL) was added NaN 3 (130 mg, 2.0 mmol). After 48 h at 80°C (bath), the reaction mixture was partitioned between CH 2 Cl 2 and saturated aqueous NaHCO 3 . The combined organic extract was dried (Na 2 SO 4 ) and concentrated. The residue was chromatographed to afford the azido alcohol 15 (111 mg, 63% yield) as a colorless oil: TLC R f (CH 2 Cl 2 /acetone ) 9.5/0.5) ) 0.20; 1 H NMR (400 MHz, CDCl 3 ) δ 3.96 (1H, s), 3.81-3.83 (1H, m), 2.36-2.42 (1H, dd, J ) 7 Hz, J ) 17 Hz), 2.21-2.27 (1H, dd, J ) 7 Hz, J ) 17 Hz), 1.90-2.06 (3H, m), 1.79-1.89 (4H, m), 1.67-1.72 (2H, m), 1.44-1.51 (1H, m), 1.40-1.42 (3H, m), 1.28-1.37 (1H, m), 1.07 (3H, s); 13 C NMR δ u 28. 1, 31.4, 32.1, 35.2, 36.9, 39.4, 46.1, 218.4; d 12.0, 36.9, 38.5, 55.1, 61.3, 68.5; IR (film) 3429, 2921 IR (film) 3429, , 2102 IR (film) 3429, , 1738 IR (film) 3429, , 1447 IR (film) 3429, , 1254 IR (film) 3429, , 1169 IR (film) 3429, , 1025 Azido Ketone 16. To a stirred solution of the azido alcohol 15 (71 mg, 0.27 mmol) in CH 2 Cl 2 (1.8 mL) at room temperature was added Dess-Martin periodinane (228 mg, 0.54 mmol). After an additional 20 min, the reaction mixture was partitioned between CH 2 Cl 2 and a 1:1 mixture of saturated aqueous Na 2 S 2 O 3 and saturated aqueous NaHCO 3 . The organic extract was dried (Na 2 SO 4 ) and concentrated. The residue was adsorbed onto silica gel and chromatographed to afford the azido ketone 16 (44 mg, 63% yield) as a colorless oil: TLC R f (CH 2 Cl 2 /acetone ) 9.5/0.5) ) 0.62; 1 H NMR (400 MHz, CDCl 3 ) δ 4.08-4.11 (1H, m), 2.41-2.55 (3H, m), 2.24-2.30 (1H, m), 1.81-2.11 (6H, m), 1.45-1.62 (3H, m), 1.20-1.29 (1H, m) 1.16 (1H, m), 1.04 (3H, s); 13 C NMR δ u 28. 6, 31.4, 35.1, 39.5, 41.6, 43.3, 206.2, 216.8; d 12.8, 37.0, 43.5, 45.7, 54.7, 63.7; IR (film) 2922 IR (film) , 2102 IR (film) , 1740 IR (film) , 1444 IR (film) , 1404 IR (film) , 1261 IR (film) , 1187 IR (film) , 1147 IR (film) , 1101 IR (film) , 1015 HRMS calcd for C 14 H 20 Pyrazine 17. Sodium hydrogen telluride was prepared by heating powdered tellurium (75 mg, 0.59 mmol) and NaBH 4 (52 mg, 1.38 mmol) to 75°C in ethanol (2.2 mL) for 1 h. To the resulting dark red solution was added azido ketone 16 (59.4 mg, 0.23 mmol) in ethanol (0.6 mL) with stirring. The color instantly turned black. The mixture was stirred open to the air overnight. The ethanol was removed under high vacuum, and then the reaction mixture was adsorbed directly onto silica gel and chromatographed to afford the heptacyclic pyrazine core 17 (41 mg, 84% yield) as a pale yellow solid: mp 185°C dec; TLC R f (CH 2 Cl 2 /acetone ) 9.5/0.5) ) 0.34; 1 H NMR (400 MHz, CDCl 3 ) δ 2.83-2.84 (2H, m) 2.61-2.75 (6H, m), 2.40-2.46 (2H, dd, J ) 7 Hz, J ) 17 Hz), 2.28-2.34 (2H, dd, J ) 7 Hz, J ) 17 Hz), 1.78-2.11 (12 H, m), 1.67-1.70 (2H, m), 1.44-1.50 (2H, m), 1.21-1.35 (2H, m), 0.84 (6H, s); 13 C NMR δ u 28. 8, 32.1, 35.3 (2), 39.8, 46.4 (2), 148.7, 149.0, 218.0; d 11.6, 37.5, 41.9, 54.4; IR (film) 2920 IR (film) , 2854 IR (film) , 1741 IR (film) , 1446 IR (film) , 1398 IR (film) , 1158 IR (film) , 1016 
